Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Scientists eye genome mapping to help chlamydia-stricken koalas

Published 03/07/2018, 06:16 pm
Updated 03/07/2018, 06:20 pm
Scientists eye genome mapping to help chlamydia-stricken koalas

SYDNEY, July 3 (Reuters) - Scientists who have mapped the genome of Australia's symbolic animal, the koala, say it could help them develop better vaccines to treat the animals, who are battling an epidemic of the bacterial disease chlamydia.

The development will also help scientists sidestep invasive procedures in investigating the biology of the marsupials, whose exact numbers are not known, but which wildlife groups estimate to range between 80,000 and 180,000.

Researchers at the Koala Genome Consortium, a team of 54 Australian and international scientists, said they sequenced more than 3.4 billion base pairs and more than 26,000 genes in the koala genome, which is slightly larger than the human one.

"We are in a great position now to be developing better vaccines to treat them," said Katherine Belov, a professor of comparative genomics at the University of Sydney.

Belov and her colleagues published their research in the journal Nature Genetics on Monday. (Link https://go.nature.com/2IQTYwg)

Left untreated, chlamydia infections can lead to blindness, severe bladder inflammation, infertility and death in koalas.

Treatment with antibiotics often makes it tough for koalas to digest the eucalyptus leaves that are a staple of their diet.

"With time, we will get to really understand why some animals recover from chlamydia and why others don't, and that will help us develop therapies to treat koalas," Belov said.

Australia classed koalas as a "vulnerable" species in a conservation measure in 2012.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Genome mapping of koalas

https://www.nature.com/articles/s41588-018-0153-5

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.